Clinical trial
CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
NCT00186680 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186680 |
|---|---|
| Title | CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant |
| Official title | Selection of CD34+THY-1 Positive Cells From Peripheral Blood Cells Procured for Autologous Hematopoietic Support Following High Dose Treatment With BCNU, Cyclophosphamide & Cisplatin for Stage IV Breast Cancer & Limited Prior Treatment |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | high dose chemo then auto hematopoietic cell transplant |
| Enrollment | 99 |
| Start date | Sep 1, 1996 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: